1. Home
  2. KALV vs MLKN Comparison

KALV vs MLKN Comparison

Compare KALV & MLKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$26.76

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo MillerKnoll Inc.

MLKN

MillerKnoll Inc.

HOLD

Current Price

$14.70

Market Cap

1.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALV
MLKN
Founded
N/A
1905
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Office Equipment/Supplies/Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2014
1994

Fundamental Metrics

Financial Performance
Metric
KALV
MLKN
Price
$26.76
$14.70
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$32.60
N/A
AVG Volume (30 Days)
5.0M
624.6K
Earning Date
07-09-2026
03-25-2026
Dividend Yield
N/A
4.71%
EPS Growth
N/A
N/A
EPS
N/A
0.98
Revenue
$50,000,000.00
$3,669,900,000.00
Revenue This Year
$185.42
$5.94
Revenue Next Year
$59.23
$3.78
P/E Ratio
N/A
$14.80
Revenue Growth
495.66
1.14
52 Week Low
$9.83
$13.77
52 Week High
$26.85
$23.18

Technical Indicators

Market Signals
Indicator
KALV
MLKN
Relative Strength Index (RSI) 74.87 37.13
Support Level $14.45 $13.81
Resistance Level N/A $16.34
Average True Range (ATR) 0.07 0.59
MACD -0.06 -0.14
Stochastic Oscillator 54.55 9.63

Price Performance

Historical Comparison
KALV
MLKN

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

About MLKN MillerKnoll Inc.

MillerKnoll Inc, formerly Herman Miller Inc researches, designs, manufactures, sells, and distributes interior furnishings across the globe. The Company has three reportable segments: Americas Contract, International Contract, and Global Retail. The company's products are sold through a variety of sources, including owned and independent contract furniture dealers, direct customer sales, owned and independent retailers, direct-mail catalogs, and the company's online stores. The independent retailer division generates the majority of the firm's overall sales.

Share on Social Networks: